Artificial intelligence (AI), especially machine learning (ML), is destined to play a key role in the future of interventional radiology (IR), according to the authors of a new study published in the Journal of Vascular and Interventional Radiology.

A recent piece in the New York Times analyzed early results of the Adolescent Brain Cognitive Development (ABCD) Study covered during CBS’s “60 Minutes,” which associated increased screen usage with lower scores on aptitude tests and further brain processes.

“If radiologists are expected to utilize machine learning models safely and effectively for imaging interpretation, education for all levels of background and experience will be required, and a formalized machine learning curriculum targeted toward early career radiologists and trainees is urgently needed," Monica J. Wood, MD and colleagues wrote.

Implantable medical devices—from pacemakers to cardioverter-defibrillators to neurostimulators—are on the rise, but their popularity in clinical practice means they’re also a prime target for ill-intentioned hackers, a trio of doctors reported in Trends in Cardiovascular Medicine in November.

An Atlanta research team has developed a smartphone app that can screen for anemia just by taking a picture of a person’s fingernails—paving the way for a new, noninvasive method to detect and diagnose the condition.

After months of back-and-forth, Envision Healthcare has renewed its contract with UnitedHealthcare.

A deep learning algorithm developed by researchers at the Mayo Clinic in Rochester, Minnesota, segmented abdominal CT images to determine body composition similarly to, and at times, better than trained radiologists.

The use of paclitaxel-coated balloons and stents in the femoropopliteal arteries of patients with peripheral artery disease (PAD) was associated with relative mortality increases of 68 percent and 93 percent at two and five years of follow-up, respectively, according to a meta-analysis published Dec. 6 in the Journal of the American Heart Association.

MaxQ AI has announced a new distribution agreement with EnvoyAI, a subsidiary of TeraRecon, that will make its Accipio intracranial hemorrhage (ICH) platform available through the EnvoyAI Exchange marketplace.

Providers saw their cancer detection rates increase by 14 percent when they made the move from film to digital mammography, according to a large study out of the U.K. published in Radiology. Recall rates, the researchers added, did not increase.